The association of diabetes mellitus with subsequent internal cancers in the arsenic-exposed area of Taiwan

Journal of Asian Earth Sciences

Volumn 73, Issue , 2013, Pages 452-459

  Hsu, Ling I ^a   Wang, Yuan Hung ^b,c   Chiou, Hung Yi ^d   Wu, Meei Maan ^d   Yang, Tse Yen ^a   Chen, Yu Hsin ^a   Tseng, Chin Hsiao ^e   Chen, Chien Jen ^a,f  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Arsenic; Diabetes mellitus; Internal cancers

Indexed keywords

ARSENIC; CANCER; CONFIDENCE INTERVAL; DIABETES; DISEASE INCIDENCE; DISEASE PREVALENCE; EPIDEMIOLOGY; HEALTH GEOGRAPHY; HEALTH IMPACT; HEALTH RISK; PUBLIC HEALTH; WELL WATER;

TAIWAN;

EID: 84879224762     PISSN: 13679120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jseaes.2013.04.048     Document Type: Article

References (51)

1. Antonelli A., Ferri C., Fallahi P., Pampana A., Ferrari S.M., Goglia F., Ferrannini E. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 2005, 28:2548-2550.
2. Ben Q., Xu M., Ning X., Liu J., Hong S., Huang W., Zhang H., Li Z. Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur. J. Cancer 2011, 47:1928-1937.
3. Bonovas S., Filioussi K., Tsantes A. Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 2004, 47:1071-1078.
4. Chang C.H., Lin J.W., Wu L.C., Lai M.S., Chuang L.M., Chan K.A. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus. Hepatology 2011.
5. Chen C.J., Chuang Y.C., Lin T.M., Wu H.Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985, 45:5895-5899.
6. Chen C.J., Wu M.M., Lee S.S., Wang J.D., Cheng S.H., Wu H.Y. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 1988, 8:452-460.
7. Chen H.F., Chen P., Li C.Y. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology 2010, 52:155-163.
8. Chen Y., Ahsan H., Slavkovich V., Peltier G.L., Gluskin R.T., Parvez F., Liu X., Graziano J.H. No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environ. Health Perspect. 2010, 118:1299-1305.
9. Chiang, T.L., 2009. Bureau of National Health Insurance. <>, (accessed 01.04.09). http://www.nhi.gov.tw/information/bulletin_file/421_0890036465-19.doc.
10. Chiou H.Y., Hsueh Y.M., Liaw K.F., Horng S.F., Chiang M.H., Pu Y.S., Lin J.S., Huang C.H., Chen C.J. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 1995, 55:1296-1300.
11. Chiou H.Y., Chiou S.T., Hsu Y.H., Chou Y.L., Tseng C.H., Wei M.L., Chen C.J. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 2001, 153:411-418.
12. Chodick G., Heymann A.D., Rosenmann L., Green M.S., Flash S., Porath A., Kokia E., Shalev V. Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control 2010, 21:879-887.
13. de Coster S., van Larebeke N. Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J. Environ. Public Health 2012, 2012:713696.
14. D'Souza R., Sabin C.A., Foster G.R. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am. J. Gastroenterol. 2005, 100:1509-1515.
15. El-Serag H.B., Hampel H., Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin. Gastroenterol. Hepatol. 2006, 4:369-380.
16. Giovannucci E., Harlan D.M., Archer M.C., Bergenstal R.M., Gapstur S.M., Habel L.A., Pollak M., Regensteiner J.G., Yee D. Diabetes and cancer: a consensus report. Diabetes Care 2010, 33:1674-1685.
17. Gribble M.O., Howard B.V., Umans J.G., Shara N.M., Francesconi K.A., Goessler W., Crainiceanu C.M., Silbergeld E.K., Guallar E., Navas-Acien A. Arsenic exposure, diabetes prevalence, and diabetes control in the strong heart study. Am. J. Epidemiol. 2012, 176:865-874.
18. Hui J.M., Sud A., Farrell G.C., Bandara P., Byth K., Kench J.G., McCaughan G.W., George J. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003, 125:1695-1704.
19. Huxley R., Ansary-Moghaddam A., Berrington de Gonzalez A., Barzi F., Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br. J. Cancer 2005, 92:2076-2083.
20. Inoue M., Iwasaki M., Otani T., Sasazuki S., Noda M., Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch. Int. Med. 2006, 166:1871-1877.
21. Jee S.H., Ohrr H., Sull J.W., Yun J.E., Ji M., Samet J.M. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005, 293:194-202.
22. Jiang Y.D., Chang C.H., Tai T.Y., Chen J.F., Chuang L.M. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database. J. Formos Med. Assoc. 2012, 111:599-604.
23. Kasper J.S., Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2056-2062.
24. Khan M., Mori M., Fujino Y., Shibata A., Sakauchi F., Washio M., Tamakoshi A. Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) study. Asian Pac. J. Cancer Prev. 2006, 7:253-259.
25. Kuo T.L. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Report Inst. Pathol. Natl. Taiwan Univ. 1964, 20:7-13.
26. Kuriki K., Hirose K., Tajima K. Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur. J. Cancer Prev. 2007, 16:83-89.
27. Lai M.S., Hsueh Y.M., Chen C.J., Shyu M.P., Chen S.Y., Kuo T.L., Wu M.M., Tai T.Y. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol. 1994, 139:484-492.
28. Lee M.Y., Lin K.D., Hsiao P.J., Shin S.J. The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism 2012, 61:242-249.
29. Li Q., Kuriyama S., Kakizaki M., Yan H., Sone T., Nagai M., Sugawara Y., Ohmori-Matsuda K., Hozawa A., Nishino Y., Tsuji I. History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study. Cancer Causes Control 2010, 21:1025-1032.
30. Lin C.C., Lai M.S., Syu C.Y., Chang S.C., Tseng F.Y. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J. Formos Med. Assoc. 2005, 104:157-163.
31. Lo M.C., Hsen Y.C., Lin B.K. The second report on the investigation of arsenic content in underground water in Taiwan Province. Sanitation 1977, Institute of Environmental Sanitation, Taichung. T.P.I.O.E. (Ed.).
32. Makris K.C., Christophi C.A., Paisi M., Ettinger A.S. A preliminary assessment of low level arsenic exposure and diabetes mellitus in Cyprus. BMC Public Health 2012, 12:334.
33. Marimuthu S.P., Vijayaragavan P., Moysich K.B., Jayaprakash V. Diabetes mellitus and gastric carcinoma: is there an association?. J. Carcinog. 2011, 10:30.
34. Mason A.L., Lau J.Y., Hoang N., Qian K., Alexander G.J., Xu L., Guo L., Jacob S., Regenstein F.G., Zimmerman R., Everhart J.E., Wasserfall C., Maclaren N.K., Perrillo R.P. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 29:328-333.
35. Maull E.A., Ahsan H., Edwards J., Longnecker M.P., Navas-Acien A., Pi J., Silbergeld E.K., Styblo M., Tseng C.H., Thayer K.A., Loomis D. Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ. Health Perspect. 2012, 120:1658-1670.
36. Mehta S.H., Brancati F.L., Strathdee S.A., Pankow J.S., Netski D., Coresh J., Szklo M., Thomas D.L. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003, 38:50-56.
37. Navas-Acien A., Silbergeld E.K., Pastor-Barriuso R., Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008, 300:814-822.
38. Patel T., Charytan D.M. Cardiovascular complications in diabetic kidney disease. Semin. Dial. 2010, 23:169-177.
39. Romero-Gomez M., Del Mar Viloria M., Andrade R.J., Salmeron J., Diago M., Fernandez-Rodriguez C.M., Corpas R., Cruz M., Grande L., Vazquez L., Munoz-de-Rueda P., Lopez-Serrano P., Gila A., Gutierrez M.L., Perez C., Ruiz-Extremera A., Suarez E., Castillo J. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005, 128:636-641.
40. Sarwar N., Gao P., Seshasai S.R., Gobin R., Kaptoge S., di Angelantonio E., Ingelsson E., Lawlor D.A., Selvin E., Stampfer M., Stehouwer C.D., Lewington S., Pennells L., Thompson A., Sattar N., White I.R., Ray K.K., Danesh J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222.
41. Seshasai S.R., Kaptoge S., Thompson A., di Angelantonio E., Gao P., Sarwar N., Whincup P.H., Mukamal K.J., Gillum R.F., Holme I., Njolstad I., Fletcher A., Nilsson P., Lewington S., Collins R., Gudnason V., Thompson S.G., Sattar N., Selvin E., Hu F.B., Danesh J. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 2011, 364:829-841.
42. Stocks T., Rapp K., Bjorge T., Manjer J., Ulmer H., Selmer R., Lukanova A., Johansen D., Concin H., Tretli S., Hallmans G., Jonsson H., Stattin P. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med. 2009, 6:e1000201.
43. Tseng C.H. Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care 2011, 34:616-621.
44. Tseng C.H. Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan. Gut 2011, 60:774-779.
45. Tseng C.H., Tai T.Y., Chong C.K., Tseng C.P., Lai M.S., Lin B.J., Chiou H.Y., Hsueh Y.M., Hsu K.H., Chen C.J. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ. Health Perspect. 2000, 108:847-851.
46. Tseng C.H., Chong C.K., Chan T.T., Bai C.H., You S.L., Chiou H.Y., Su T.C., Chen C.J. Optimal anthropometric factor cutoffs for hyperglycemia, hypertension and dyslipidemia for the Taiwanese population. Atherosclerosis 2010, 210:585-589.
47. Tseng L.N., Tseng Y.H., Jiang Y.D., Chang C.H., Chung C.H., Lin B.J., Chuang L.M., Tai T.Y., Sheu W.H. Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009. J. Formos Med. Assoc. 2012, 111:625-636.
48. Waters K.M., Henderson B.E., Stram D.O., Wan P., Kolonel L.N., Haiman C.A. Association of diabetes with prostate cancer risk in the multiethnic cohort. Am. J. Epidemiol. 2009, 169:937-945.
49. Weiderpass E., Ye W., Vainio H., Kaaks R., Adami H.O. Reduced risk of prostate cancer among patients with diabetes mellitus. Int. J. Cancer 2002, 102:258-261.
50. White D.L., Ratziu V., El-Serag H.B. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J. Hepatol. 2008, 49:831-844.
51. Yamagata H., Kiyohara Y., Nakamura S., Kubo M., Tanizaki Y., Matsumoto T., Tanaka K., Kato I., Shirota T., Iida M. Impact of fasting plasma glucose levels on gastric cancer incidence in a general Japanese population: the Hisayama study. Diabetes Care 2005, 28:789-794.